Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
293.22
-2.74 (-0.93%)
Nov 28, 2025, 4:00 PM EST - Market closed
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$296,400
Profits / Employee
$36,450
Market Cap
11.48B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PEN News
- 8 days ago - Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 22 days ago - Penumbra, Inc. (PEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Penumbra, Inc. Reports Third Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism - PRNewsWire
- 4 weeks ago - Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism - PRNewsWire
- 4 weeks ago - Penumbra, Inc. (PEN) Presents at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 Transcript - Seeking Alpha
- 7 weeks ago - Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025 - PRNewsWire
- 2 months ago - Penumbra, Inc. (PEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha